Back
Strategy Shares Nasdaq 7 Handl™ ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
49
HNDL
Strategy Shares Nasdaq 7 Handl™ ETF
Last Price:
22.14
Seasonality Move:
1.78%
Buy
51
LBPH
Longboard Pharmaceuticals
Last Price:
36.10
Seasonality Move:
-17.08%
Sell
49
Strategy Shares Nasdaq 7 Handl™ ETF (HNDL)
is a Sell
Is Strategy Shares Nasdaq 7 Handl™ ETF a Buy, Sell or Hold?
- The current Strategy Shares Nasdaq 7 Handl™ ETF [HNDL] share price is $22.18. The Score for HNDL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- HNDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $36.22. The Score for LBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HNDL Stock Price Chart
What is Strategy Shares Nasdaq 7 Handl™ ETF's stock price today?
-
The Strategy Shares Nasdaq 7 Handl™ ETF share price today is $22.18
The current trend is moderately bullish and HNDL is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $36.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
HNDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 56.38 | Buy |
| Chaikin Money Flow: | 70815 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.94 - 22.26) | Buy |
| Bollinger Bands (100): | (20.95 - 21.93) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 57.18 | Buy |
| Chaikin Money Flow: | -274481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.33 - 35.83) | Buy |
| Bollinger Bands (100): | (22.58 - 37.02) | Buy |
HNDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.21 | Sell |
| 20-day SMA: | 22.16 | Buy |
| 50-day SMA: | 21.79 | Buy |
| 200-day SMA: | 21.06 | Buy |
| 8-day EMA: | 22.2 | Sell |
| 20-day EMA: | 22.13 | Buy |
| 50-day EMA: | 21.86 | Buy |
| 200-day EMA: | 21.14 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.21 | Buy |
| 20-day SMA: | 33.26 | Buy |
| 50-day SMA: | 34.3 | Buy |
| 200-day SMA: | 24.85 | Buy |
| 8-day EMA: | 34.89 | Buy |
| 20-day EMA: | 34.02 | Buy |
| 50-day EMA: | 33.21 | Buy |
| 200-day EMA: | 25.16 | Buy |
Strategy Shares Nasdaq 7 Handl™ ETF Earnings Growth & HNDL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Strategy Shares Nasdaq 7 Handl™ ETF Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||